Cargando…
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not containe...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073201/ https://www.ncbi.nlm.nih.gov/pubmed/27684603 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348 |
_version_ | 1782461526239608832 |
---|---|
author | Pebody, Richard Warburton, Fiona Ellis, Joanna Andrews, Nick Potts, Alison Cottrell, Simon Johnston, Jillian Reynolds, Arlene Gunson, Rory Thompson, Catherine Galiano, Monica Robertson, Chris Byford, Rachel Gallagher, Naomh Sinnathamby, Mary Yonova, Ivelina Pathirannehelage, Sameera Donati, Matthew Moore, Catherine de Lusignan, Simon McMenamin, Jim Zambon, Maria |
author_facet | Pebody, Richard Warburton, Fiona Ellis, Joanna Andrews, Nick Potts, Alison Cottrell, Simon Johnston, Jillian Reynolds, Arlene Gunson, Rory Thompson, Catherine Galiano, Monica Robertson, Chris Byford, Rachel Gallagher, Naomh Sinnathamby, Mary Yonova, Ivelina Pathirannehelage, Sameera Donati, Matthew Moore, Catherine de Lusignan, Simon McMenamin, Jim Zambon, Maria |
author_sort | Pebody, Richard |
collection | PubMed |
description | The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not contained in that season’s adult trivalent inactivated influenza vaccine (IIV). Overall adjusted end-of-season vaccine effectiveness (VE) was 52.4% (95% confidence interval (CI): 41.0–61.6) against influenza-confirmed primary care consultation, 54.5% (95% CI: 41.6–64.5) against influenza A(H1N1)pdm09 and 54.2% (95% CI: 33.1–68.6) against influenza B. In 2–17 year-olds, adjusted VE for LAIV was 57.6% (95% CI: 25.1 to 76.0) against any influenza, 81.4% (95% CI: 39.6–94.3) against influenza B and 41.5% (95% CI: −8.5 to 68.5) against influenza A(H1N1)pdm09. These estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09. Despite lineage mismatch in the trivalent IIV, adults younger than 65 years were still protected against influenza B. These results provide reassurance for the UK to continue its influenza immunisation programme planned for 2016/17. |
format | Online Article Text |
id | pubmed-5073201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-50732012016-11-07 Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results Pebody, Richard Warburton, Fiona Ellis, Joanna Andrews, Nick Potts, Alison Cottrell, Simon Johnston, Jillian Reynolds, Arlene Gunson, Rory Thompson, Catherine Galiano, Monica Robertson, Chris Byford, Rachel Gallagher, Naomh Sinnathamby, Mary Yonova, Ivelina Pathirannehelage, Sameera Donati, Matthew Moore, Catherine de Lusignan, Simon McMenamin, Jim Zambon, Maria Euro Surveill Surveillance and Outbreak Report The United Kingdom (UK) is in the third season of introducing universal paediatric influenza vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 season in the UK was initially dominated by influenza A(H1N1)pdm09 and then influenza of B/Victoria lineage, not contained in that season’s adult trivalent inactivated influenza vaccine (IIV). Overall adjusted end-of-season vaccine effectiveness (VE) was 52.4% (95% confidence interval (CI): 41.0–61.6) against influenza-confirmed primary care consultation, 54.5% (95% CI: 41.6–64.5) against influenza A(H1N1)pdm09 and 54.2% (95% CI: 33.1–68.6) against influenza B. In 2–17 year-olds, adjusted VE for LAIV was 57.6% (95% CI: 25.1 to 76.0) against any influenza, 81.4% (95% CI: 39.6–94.3) against influenza B and 41.5% (95% CI: −8.5 to 68.5) against influenza A(H1N1)pdm09. These estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09. Despite lineage mismatch in the trivalent IIV, adults younger than 65 years were still protected against influenza B. These results provide reassurance for the UK to continue its influenza immunisation programme planned for 2016/17. European Centre for Disease Prevention and Control (ECDC) 2016-09-22 /pmc/articles/PMC5073201/ /pubmed/27684603 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348 Text en This article is copyright of The Authors, 2016. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Surveillance and Outbreak Report Pebody, Richard Warburton, Fiona Ellis, Joanna Andrews, Nick Potts, Alison Cottrell, Simon Johnston, Jillian Reynolds, Arlene Gunson, Rory Thompson, Catherine Galiano, Monica Robertson, Chris Byford, Rachel Gallagher, Naomh Sinnathamby, Mary Yonova, Ivelina Pathirannehelage, Sameera Donati, Matthew Moore, Catherine de Lusignan, Simon McMenamin, Jim Zambon, Maria Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title | Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title_full | Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title_fullStr | Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title_full_unstemmed | Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title_short | Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results |
title_sort | effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the united kingdom: 2015/16 end-of-season results |
topic | Surveillance and Outbreak Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073201/ https://www.ncbi.nlm.nih.gov/pubmed/27684603 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.38.30348 |
work_keys_str_mv | AT pebodyrichard effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT warburtonfiona effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT ellisjoanna effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT andrewsnick effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT pottsalison effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT cottrellsimon effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT johnstonjillian effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT reynoldsarlene effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT gunsonrory effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT thompsoncatherine effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT galianomonica effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT robertsonchris effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT byfordrachel effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT gallaghernaomh effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT sinnathambymary effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT yonovaivelina effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT pathirannehelagesameera effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT donatimatthew effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT moorecatherine effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT delusignansimon effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT mcmenaminjim effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults AT zambonmaria effectivenessofseasonalinfluenzavaccineforadultsandchildreninpreventinglaboratoryconfirmedinfluenzainprimarycareintheunitedkingdom201516endofseasonresults |